Effects of chronic treatment with the new ultra-long-acting β(2)-adrenoceptor agonist indacaterol alone or in combination with the β(1)-adrenoceptor blocker metoprolol on cardiac remodelling

BACKGROUND AND PURPOSE: The ability of a chronic treatment with indacaterol, a new ultra-long-acting β(2)-adrenoceptor agonist, to reverse cardiac remodelling and its effects in combination with metoprolol, a selective β(1)-adrenoceptor antagonist, were investigated on myocardial infarction in a rat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Pharmacol
Glavni autori: Rinaldi, Barbara, Donniacuo, Maria, Sodano, Loredana, Gritti, Giulia, Martuscelli, Eugenio, Orlandi, Augusto, Rafaniello, Concetta, Rossi, Francesco, Calzetta, Luigino, Capuano, Annalisa, Matera, Maria Gabriella
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2015
Teme:
Research Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4507164/
https://ncbi.nlm.nih.gov/pubmed/25825265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13148
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items